Nothing Special   »   [go: up one dir, main page]

MX2016000116A - Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana. - Google Patents

Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana.

Info

Publication number
MX2016000116A
MX2016000116A MX2016000116A MX2016000116A MX2016000116A MX 2016000116 A MX2016000116 A MX 2016000116A MX 2016000116 A MX2016000116 A MX 2016000116A MX 2016000116 A MX2016000116 A MX 2016000116A MX 2016000116 A MX2016000116 A MX 2016000116A
Authority
MX
Mexico
Prior art keywords
antimicrobial activity
organic compound
volatile organic
compound formulations
formulations
Prior art date
Application number
MX2016000116A
Other languages
English (en)
Inventor
Blatt Bryan
Original Assignee
Cineole Corp Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cineole Corp Llc filed Critical Cineole Corp Llc
Publication of MX2016000116A publication Critical patent/MX2016000116A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención incluye formulaciones químicas nuevas que tienen actividad antimicrobiana y sus métodos de uso; en algunas modalidades, la formulación comprende además por lo menos un hongo.
MX2016000116A 2013-07-02 2014-07-02 Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana. MX2016000116A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361842362P 2013-07-02 2013-07-02
US201461948902P 2014-03-06 2014-03-06
PCT/US2014/045297 WO2015003082A2 (en) 2013-07-02 2014-07-02 Volatile organic compound formulations having antimicrobial activity

Publications (1)

Publication Number Publication Date
MX2016000116A true MX2016000116A (es) 2017-04-25

Family

ID=52144286

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000116A MX2016000116A (es) 2013-07-02 2014-07-02 Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana.

Country Status (12)

Country Link
US (2) US10117841B2 (es)
EP (2) EP3017054B1 (es)
CN (1) CN106414752A (es)
AU (3) AU2014284267B2 (es)
BR (1) BR112015032961B1 (es)
CA (1) CA2917149C (es)
DK (1) DK3017054T3 (es)
ES (1) ES2769893T3 (es)
MX (1) MX2016000116A (es)
PL (1) PL3017054T3 (es)
RU (1) RU2673737C2 (es)
WO (1) WO2015003082A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CA3030660C (en) * 2016-07-19 2023-01-17 National Institute Of Plant Genome Research Mutated protein from burkholderia gladioli strain ngj1 against fungal pathogens
EP3856165A4 (en) * 2018-09-28 2022-06-08 EcoPlanet Environmental LLC FORMULATIONS OF VOLATILE ORGANIC COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
US12097173B2 (en) 2019-09-27 2024-09-24 Ecoplanet Environmental Llc Volatile organic compound formulations having antimicrobial activity
CN111686399B (zh) * 2020-05-29 2022-05-24 华南理工大学 一种抑制细菌在金属诱导下抗生素抗性基因表达的试剂及其制备方法与应用
US20240237661A1 (en) * 2023-01-17 2024-07-18 Ecoplanet Environmental Llc Antimicrobial solutions and uses thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914131A (en) * 1971-08-23 1975-10-21 Emery Industries Inc Useful wax compositions
US3898328A (en) 1973-12-03 1975-08-05 Syntex Inc Dry stable composition for the treatment of scours and dehydration
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5169645A (en) 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
WO1993018755A1 (en) 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
FI100376B (fi) * 1995-02-06 1997-11-28 Kemira Oyj Uusi säilöntäainekoostumus
WO1997047285A1 (en) 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US5972389A (en) 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
US6635280B2 (en) 1997-06-06 2003-10-21 Depomed, Inc. Extending the duration of drug release within the stomach during the fed mode
WO1998055107A1 (en) 1997-06-06 1998-12-10 Depomed, Inc. Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
WO2001032217A2 (en) 1999-11-02 2001-05-10 Depomed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
ES2270982T3 (es) 2000-02-04 2007-04-16 Depomed, Inc. Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
GB0011675D0 (en) * 2000-05-15 2000-07-05 Unilever Plc Ambient stable beverage
GB0011677D0 (en) * 2000-05-15 2000-07-05 Unilever Plc Ambient stable beverage
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6451808B1 (en) 2000-10-17 2002-09-17 Depomed, Inc. Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
WO2002096404A1 (en) 2001-05-29 2002-12-05 Depomed Development Ltd Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
US20030091630A1 (en) 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2464561A1 (en) 2001-10-25 2003-05-01 Depomed, Inc. Methods of treatment using a gastric retained losartan dosage
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7407675B2 (en) 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
RU2385738C2 (ru) * 2005-10-05 2010-04-10 Ска Хайджин Продактс Аб Впитывающее изделие, содержащее тонкую пленку, включающую активное вещество
JP5134258B2 (ja) * 2007-02-09 2013-01-30 ユニ・チャーム株式会社 動物用トイレ砂
JO3416B1 (ar) * 2009-04-27 2019-10-20 Jeneil Biosurfactant Co Llc تركيبات مضادة للبكتيريا وطرق استخدامها
CN102917606A (zh) 2010-06-03 2013-02-06 斯托克里-丰康普公司 提供减少的咸味的电解质掺和物
JP5447348B2 (ja) * 2010-11-15 2014-03-19 トヨタ自動車株式会社 微生物及びその菌体を含有する脱臭剤
KR20140097253A (ko) 2011-11-30 2014-08-06 아니톡스 코포레이션 알데히드, 유기산 및 유기산 에스테르의 항미생물성 혼합물
CN102511505B (zh) * 2011-12-08 2014-05-07 厦门大学 一种互花米草的抑制剂及其制备方法
US20150208606A1 (en) 2012-08-27 2015-07-30 The All Natural Pet Litter Company Pty Ltd Odour controller

Also Published As

Publication number Publication date
EP3017054A2 (en) 2016-05-11
RU2018139976A3 (es) 2021-11-18
US10117841B2 (en) 2018-11-06
CA2917149A1 (en) 2015-01-08
AU2019229354A1 (en) 2019-10-03
RU2016103137A (ru) 2017-08-07
AU2019229354B2 (en) 2022-06-30
AU2018214127B2 (en) 2019-06-13
WO2015003082A2 (en) 2015-01-08
PL3017054T3 (pl) 2020-07-13
US20160250167A1 (en) 2016-09-01
BR112015032961B1 (pt) 2021-11-30
DK3017054T3 (da) 2020-02-17
ES2769893T3 (es) 2020-06-29
WO2015003082A3 (en) 2015-11-26
EP3017054A4 (en) 2017-01-04
EP3613861A1 (en) 2020-02-26
AU2014284267A1 (en) 2016-02-04
AU2018214127A1 (en) 2018-08-30
NZ715859A (en) 2021-03-26
CN106414752A (zh) 2017-02-15
AU2014284267B2 (en) 2018-05-10
BR112015032961A2 (pt) 2018-01-23
US20190269634A1 (en) 2019-09-05
NZ754916A (en) 2021-05-28
AU2018214127A2 (en) 2018-11-29
CA2917149C (en) 2021-02-02
US11285120B2 (en) 2022-03-29
RU2673737C2 (ru) 2018-11-29
RU2018139976A (ru) 2019-04-03
EP3017054B1 (en) 2019-11-13

Similar Documents

Publication Publication Date Title
MD3209310T2 (ro) Compoziții care conțin tulpini bacteriene
NZ731029A (en) An antimicrobial composition
CL2015001985A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim.
UY34605A (es) Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
MY179756A (en) Stabilized efinaconazole formulations
MX363004B (es) Formulaciones desinfectantes tópicas y usos de las mismas.
MX2015011897A (es) Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
MX2015017636A (es) Mezclas fungicidas i que comprenden fungicidas de tipo estrobilurina.
MX2016008448A (es) Conjugados de var2csa-farmaco.
PH12015501888A1 (en) Novel bacteriophage and antibacterial composition comprising the same
MX367326B (es) Composiciones antimicrobianas.
MX2016000116A (es) Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana.
MX2016013894A (es) Composicion para el cuidado del cuero cabelludo.
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
IN2014DN11078A (es)
MX2019010330A (es) Formulaciones con mejora de la estabilidad.
MX2016004078A (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX359955B (es) Formulación de aroma y fragancia (iii).
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
BR112016020374A2 (pt) formulação, e, métodos para potenciar o crescimento de plantas e para formular um ou mais agentes agricolamente benéficos
NZ706842A (en) Topical parasiticidal formulation